EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)

Xiaolu Zhang, Ziyu Wang, Yujia Zheng, Qun Yu, Miao Zeng, Liding Bai, Lin Yang, Maojuan Guo, Xijuan Jiang, Jiali Gan

International Journal of Molecular Medicine · 21.03.2023 · 51 (4)

DOI: 10.3892/ijmm.2023.5238 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 21.03.2023. Verfasst von Xiaolu Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China. Hauptthemen laut MEDLINE: Inflammasomes, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 134-mal zitiert (Crossref) und nennt 219 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The inflammasome regulates innate immunity by serving as a signaling platform. The Nod‑like receptor protein 3 (NLRP3) inflammasome, equipped with NLRP3, the adaptor protein apoptosis‑associated speck‑like protein (ASC) and pro‑caspase‑1, is by far the most extensively studied and well‑characterized inflammasome. A variety of stimuli can activate the NLRP3 inflammasome. When activated, the NLRP3 protein recruits the adaptor ASC protein and activates pro‑caspase‑1, resulting in inflammatory cytokine maturation and secretion, which is associated with inflammation and pyroptosis. However, the aberrant activation of the NLRP3 inflammasome has been linked to various inflammatory diseases, including atherosclerosis, ischemic stroke, Alzheimer's disease, diabetes mellitus and inflammatory bowel disease. Therefore, the NLRP3 inflammasome has emerged as a promising therapeutic target for inflammatory diseases. In the present review, systematic searches were performed using 'NLRP3 inhibitor(s)' and 'inflammatory disease(s)' as key words. By browsing the literature from 2012 to 2022, 100 articles were retrieved, of which 35 were excluded as they were reviews, editorials, retracted or unavailable online, and 65 articles were included. According to the retrieved literature, the current understanding of NLRP3 inflammasome pathway activation in inflammatory diseases was summarize, and inhibitors of the NLRP3 inflammasome pathway targeting the NLRP3 protein and other inflammasome components or products were highlighted. Additionally, the present review briefly discusses the current novel efforts in clinical research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinHumansNLR ProteinsCaspase 1Inflammation

Stichwörter der Autor:innen

Nod‑like receptor protein 3 inflammasome inhibitorsclinical perspectivesinflammationinflammatory diseasespyroptosis

Substanzen

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNLR ProteinsCaspase 1

Autor:innen und Institutionen

  • School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
  • College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.

Zitieren

APA

Zhang, X., Wang, Z., Zheng, Y., Yu, Q., Zeng, M., Bai, L., Yang, L., Guo, M., Jiang, X., & Gan, J. (2023). Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review). International Journal of Molecular Medicine, 51(4). https://doi.org/10.3892/ijmm.2023.5238

Vancouver

Zhang X, Wang Z, Zheng Y, Yu Q, Zeng M, Bai L, et al. Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review). International Journal of Molecular Medicine. 2023;51(4). doi:10.3892/ijmm.2023.5238

BibTeX
@article{Zhang2023,
  author = {Zhang, Xiaolu and Wang, Ziyu and Zheng, Yujia and Yu, Qun and Zeng, Miao and Bai, Liding and Yang, Lin and Guo, Maojuan and Jiang, Xijuan and Gan, Jiali},
  title = {Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2023},
  volume = {51},
  number = {4},
  doi = {10.3892/ijmm.2023.5238}
}
Kostenlos starten →